{"id":"edetate-calcium-disodium","safety":{"commonSideEffects":[{"rate":null,"effect":"Nephrotoxicity (kidney damage)"},{"rate":null,"effect":"Hypocalcemia (low blood calcium)"},{"rate":null,"effect":"Zinc depletion"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Headache"}]},"_chembl":null,"_dailymed":{"setId":"710a2c8c-3620-4f6f-b8fc-fb19ab9e9f22","title":"EDETATE CALCIUM DISODIUM INJECTION [RISING PHARMA HOLDINGS, INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The drug contains a chelate structure with multiple binding sites that preferentially bind divalent and trivalent metal cations, especially lead, while releasing calcium. It forms soluble complexes with heavy metals in the bloodstream and tissues, facilitating their urinary elimination without significantly depleting essential minerals when used appropriately.","oneSentence":"Edetate calcium disodium is a chelating agent that binds and removes heavy metals (particularly lead) from the body by forming stable complexes that are excreted in urine.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:45:14.721Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Lead poisoning (acute and chronic lead toxicity)"},{"name":"Heavy metal poisoning"}]},"trialDetails":[{"nctId":"NCT06982222","phase":"PHASE1","title":"Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-03-31","conditions":"Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Lung Non-Small Cell Carcinoma","enrollment":24},{"nctId":"NCT07159074","phase":"PHASE2","title":"Repurposing Tilmanocept for Cardiac Sarcoidosis","status":"RECRUITING","sponsor":"Duke University","startDate":"2025-09-17","conditions":"Cardiac Sarcoidosis","enrollment":15},{"nctId":"NCT07191262","phase":"NA","title":"To Compare Post-Extraction Use of a Novel Ethylenediaminetetraacetic Acid (EDTA) Post-operative Mouth Rinse and Daily Use EDTA Mouth Rinse and Standard 0.12% Chlorhexidine (CHX) Post-operative Mouth Rinse and Daily Use Essential Oil (EO) Mouth Rinse.","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-03-02","conditions":"Extraction Sites After Removal and Bone Replacement Grafting at Extraction Sockets of Dentally Hopeless Single-rooted Teeth","enrollment":40},{"nctId":"NCT05275686","phase":"PHASE2","title":"Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD)","status":"RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2022-04-20","conditions":"Eustachian Tube Dysfunction","enrollment":80},{"nctId":"NCT03894657","phase":"NA","title":"Validation of Respiratory Epithelial Functional Assessment to Predict Clinical Efficacy of Orkambi®.","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2019-12-18","conditions":"Cystic Fibrosis, Homozygous F508del Mutation","enrollment":91},{"nctId":"NCT06750653","phase":"PHASE4","title":"Skin Barrier Function and Inflammation in Aging: The BIA Study","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2025-02-06","conditions":"Inflammation, Skin Inflammation, Aging","enrollment":32},{"nctId":"NCT01874769","phase":"","title":"Study of Immune Tolerance and Capacity for Wound Healing of Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2013-08","conditions":"Recessive Dystrophic Epidermolysis Bullosa","enrollment":30},{"nctId":"NCT03630991","phase":"PHASE1","title":"Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2018-10-11","conditions":"Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive","enrollment":58},{"nctId":"NCT05533528","phase":"NA","title":"Periodontal Granulation Tissue Preservation in Surgical Periodontitis Treatment","status":"RECRUITING","sponsor":"Universidad de Murcia","startDate":"2022-05-03","conditions":"Periodontal Pocket, Periodontal Diseases, Periodontal Bone Loss","enrollment":25},{"nctId":"NCT04288323","phase":"PHASE4","title":"Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2018-04-27","conditions":"Liver Cancer, Liver Cirrhoses, Liver Carcinoma","enrollment":79},{"nctId":"NCT07267013","phase":"PHASE2","title":"Clindamycin as an Alternative to Vancomycin in Patients Undergoing Aortic Cardiac Surgery With Extracorporeal Circulation (ECC)","status":"NOT_YET_RECRUITING","sponsor":"Nantes University Hospital","startDate":"2026-03-30","conditions":"Aortic Surgery, Extracorporeal Circulation","enrollment":25},{"nctId":"NCT07353008","phase":"NA","title":"Effect of Different Chelation Protocols on the Healing of Periapical Lesions in Teeth With Chronic Apical Periodontitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mustafa Kemal University","startDate":"2025-12-01","conditions":"Chronic Apical Periodontitis","enrollment":63},{"nctId":"NCT07355816","phase":"NA","title":"Effect of Different Root Canal Disinfection Procedures on Postoperative Pain","status":"COMPLETED","sponsor":"Cumhuriyet University","startDate":"2023-06-13","conditions":"Pain, Postoperative","enrollment":80},{"nctId":"NCT06716021","phase":"PHASE3","title":"ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3","status":"NOT_YET_RECRUITING","sponsor":"Milestone Pharmaceuticals Inc.","startDate":"2027-01","conditions":"Atrial Fibrillation","enrollment":750},{"nctId":"NCT07339605","phase":"NA","title":"Flapless Periodontal Regeneration Using Hyaluronic Acid Versus Enamel Matrix Derivative","status":"RECRUITING","sponsor":"University of Valencia","startDate":"2024-10-26","conditions":"Guided Tissue Regeneration, Periodontal / Methods, Dental Enamel Proteins* / Therapeutic Use, Alveolar Bone Loss* / Therapy","enrollment":60},{"nctId":"NCT05428007","phase":"PHASE2","title":"Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma","status":"RECRUITING","sponsor":"NYU Langone Health","startDate":"2023-02-02","conditions":"Melanoma, Unresectable Melanoma","enrollment":105},{"nctId":"NCT06016088","phase":"PHASE1, PHASE2","title":"A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection","status":"RECRUITING","sponsor":"Respirion Pharmaceuticals Pty Ltd","startDate":"2024-04-01","conditions":"Cystic Fibrosis Lung, Respiratory Infections, Recurrent, Chronic, Pseudomonas Aeruginosa","enrollment":72},{"nctId":"NCT02156739","phase":"NA","title":"Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2014-10-13","conditions":"Hepatocellular Carcinoma, Liver and Intrahepatic Bile Duct Disorder, Metastatic Malignant Neoplasm in the Liver","enrollment":100},{"nctId":"NCT05384132","phase":"NA","title":"Novel Dental Gel as an Adjunct to Scaling and Root Planing","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2022-10-14","conditions":"Periodontal Diseases, Gingival Diseases, Gingival Pocket","enrollment":76},{"nctId":"NCT07265804","phase":"NA","title":"PRF and CGF Scaffolds With EDTA in Regeneration","status":"COMPLETED","sponsor":"Kahramanmaras Sutcu Imam University","startDate":"2023-10-01","conditions":"Pulp Necrosis, Immature Permanent Teeth, Open Apex","enrollment":30},{"nctId":"NCT07254260","phase":"","title":"Photodynamic Therapy and Post-Endodontic Pain in Undergraduate-Performed Treatments","status":"COMPLETED","sponsor":"Atlas University","startDate":"2025-01-01","conditions":"Pulpitis","enrollment":95},{"nctId":"NCT07053696","phase":"PHASE1","title":"Pharmacokinetics, Safety, and Lung Deposition of 99mTc-DTPA Delivered Via the EDDIS System in Healthy Volunteers","status":"WITHDRAWN","sponsor":"Andrey Petrov","startDate":"2025-03-17","conditions":"Healthy Volunteers","enrollment":""},{"nctId":"NCT07233733","phase":"NA","title":"A Clinical Study of Connective Tissue Graft and Enamel Matrix Derivative in the Treatment of Intrabony Periodontal Defects","status":"COMPLETED","sponsor":"Phạm Đình Thiên Khải","startDate":"2024-06-01","conditions":"Periodontal Diseases, Regeneration","enrollment":17},{"nctId":"NCT05879835","phase":"NA","title":"KiteLock 4% EDTA Lock Solution for the Prevention of Occlusions in Children With Intestinal Failure","status":"RECRUITING","sponsor":"SterileCare Inc.","startDate":"2024-06-21","conditions":"Pediatric Intestinal Failure","enrollment":124},{"nctId":"NCT03694756","phase":"NA","title":"TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer","status":"RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2018-12-12","conditions":"Breast Cancer","enrollment":95},{"nctId":"NCT04299867","phase":"","title":"Perioperative Tissue Penetration of Antimicrobials in Infants","status":"COMPLETED","sponsor":"Duke University","startDate":"2020-07-15","conditions":"Bowel Dysfunction","enrollment":21},{"nctId":"NCT04893577","phase":"PHASE2","title":"EDTA Eye Drops Compared to Abreva for Herpes Simplex Virus Eruptions","status":"COMPLETED","sponsor":"University of Utah","startDate":"2022-01-20","conditions":"Herpes Simplex Oral","enrollment":10},{"nctId":"NCT04681066","phase":"PHASE2","title":"A Study of Auxora in Patients With Acute Pancreatitis and Accompanying SIRS","status":"COMPLETED","sponsor":"CalciMedica, Inc.","startDate":"2021-03-24","conditions":"Acute Pancreatitis, Systemic Inflammatory Response Syndrome","enrollment":216},{"nctId":"NCT06710964","phase":"NA","title":"Inducing Self-Dehumanization to Examine Oxytocin and Suicide Risk","status":"NOT_YET_RECRUITING","sponsor":"Florida State University","startDate":"2026-04","conditions":"Mechanistic Self-Dehumanization Condition, Control Condition","enrollment":50},{"nctId":"NCT07207668","phase":"NA","title":"i-PRF & Root Surface Biomodification","status":"COMPLETED","sponsor":"Halil Ata BIÇAKÇIOGLU","startDate":"2023-02-01","conditions":"Chronic Periodontitis (Disorder), Periodontitis","enrollment":42},{"nctId":"NCT04616547","phase":"PHASE2","title":"Treatment of Cancer-Related Bone Pain by Using Bone-Targeted Radiation-Based Therapy (Sn-117m-DTPA) in Patients With Prostate Cancer That Has Spread to Bones","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2021-12-18","conditions":"Castration-Resistant Prostate Carcinoma, Metastatic Malignant Neoplasm in the Bone, Metastatic Prostate Adenocarcinoma","enrollment":1},{"nctId":"NCT07192289","phase":"NA","title":"Using Platelet-rich Fibrin in Regenerative Endodontic Treatment in Mature Permanent Teeth","status":"NOT_YET_RECRUITING","sponsor":"University of Medicine and Pharmacy at Ho Chi Minh City","startDate":"2025-09-15","conditions":"Chronic Apical Periodontitis, Necrosis of Pulp, Acute Apical Periodontitis of Pulpal Origin","enrollment":57},{"nctId":"NCT05351983","phase":"NA","title":"Patient-derived Organoids Drug Screen in Pancreatic Cancer","status":"COMPLETED","sponsor":"Prof. Dr. med. Dres. h.c. Jan Schmidt, MME","startDate":"2022-09-22","conditions":"Pancreas Cancer, Pancreas Neoplasm, Pancreas Adenocarcinoma","enrollment":60},{"nctId":"NCT07183631","phase":"PHASE4","title":"Healing of Intrabony Defects Following Treatment With PRF or EMD","status":"COMPLETED","sponsor":"Semmelweis University","startDate":"2021-09-01","conditions":"Periodontal Bone Loss, Periodontal Disease, Platelet Rich Fibrin","enrollment":28},{"nctId":"NCT06152250","phase":"NA","title":"Characterization of the Intrahepatic Inflammatory Microenvironment in Patients With Non-alcoholic Steatohepatitis","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2023-01-29","conditions":"Liver Diseases","enrollment":60},{"nctId":"NCT05632484","phase":"NA","title":"Genotype Expression and Phenotype of Endothelial Cells, Carrying an ACVRL1, ENG or SMAD4 Mutation, in Response to BMP9 for the Identification of New Therapeutic Targets in Hereditary Haemorrhagic Telangiectasia","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2023-03-10","conditions":"Hereditary Haemorrhagic Telangiectasia","enrollment":16},{"nctId":"NCT07133217","phase":"NA","title":"Comparative Evaluation of Postoperative Pain and Clinical Success","status":"COMPLETED","sponsor":"Ege University","startDate":"2024-06-11","conditions":"Symptomatic Irreversible Pulpitis","enrollment":63},{"nctId":"NCT07121595","phase":"PHASE2","title":"Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial","status":"RECRUITING","sponsor":"University of Michigan Rogel Cancer Center","startDate":"2025-07-17","conditions":"Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8","enrollment":50},{"nctId":"NCT07119905","phase":"","title":"Association Between Matrix Metalloproteinase-9 Gene Polymorphism and Susceptibility to Primary Open Angle Glaucoma Patients in Sohag University Hospital","status":"NOT_YET_RECRUITING","sponsor":"Sohag University","startDate":"2026-06-01","conditions":"Primary Open Angle Glaucoma (POAG)","enrollment":80},{"nctId":"NCT07116252","phase":"NA","title":"Effect of Different Irrigation Protocols on Postoperative Endodontic Pain and Inflammation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Suez Canal University","startDate":"2023-08-20","conditions":"Irrigation Solution, Postoperative Pain, Inflammation","enrollment":75},{"nctId":"NCT07106320","phase":"NA","title":"Evaluation of Different Root Canal Irrigation Techniques","status":"COMPLETED","sponsor":"Medipol University","startDate":"2023-11-15","conditions":"Apical Periodontitis","enrollment":162},{"nctId":"NCT06247826","phase":"NA","title":"Mechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion","status":"RECRUITING","sponsor":"Groupe Francais De Pneumo-Cancerologie","startDate":"2024-01-15","conditions":"Non-small Cell Lung Cancer, EGFR Exon 20 Insertion Mutation","enrollment":30},{"nctId":"NCT05501756","phase":"PHASE2","title":"Precision Alemtuzumab Dosing for Allogeneic Hematopoietic Cell Transplantation","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2023-01-11","conditions":"Allogeneic Hematopoietic Cell Transplantation","enrollment":60},{"nctId":"NCT07057336","phase":"NA","title":"Evaluation of Post-Operative Pain Following the Use of Nano-Calcium Hydroxide","status":"COMPLETED","sponsor":"Cukurova University","startDate":"2024-05-14","conditions":"Chronic Apical Periodontitis","enrollment":90},{"nctId":"NCT05451771","phase":"PHASE1, PHASE2","title":"Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis","status":"RECRUITING","sponsor":"Rajshekhar Chakraborty, MD","startDate":"2022-10-26","conditions":"AL Amyloidosis","enrollment":53},{"nctId":"NCT04942158","phase":"NA","title":"Non-instrumentation Root Canal Treatment of Primary Molars","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2021-10-04","conditions":"Dental Pulp Diseases, Dental Pulp Necrosis","enrollment":180},{"nctId":"NCT07033247","phase":"NA","title":"The Effect of Different Sodium Hypochlorite Concentrations and Activation Techniques on Postoperative Pain","status":"COMPLETED","sponsor":"Cukurova University","startDate":"2024-12-11","conditions":"Chronic Apical Periodontitis","enrollment":120},{"nctId":"NCT06116253","phase":"NA","title":"Advanced Diffusion Imaging in Renal Cancer Patients","status":"RECRUITING","sponsor":"NYU Langone Health","startDate":"2022-12-01","conditions":"Renal Cancer","enrollment":90},{"nctId":"NCT07005804","phase":"NA","title":"Calcium Pyrophosphate Deposition (CPPD) Disease","status":"NOT_YET_RECRUITING","sponsor":"Lille Catholic University","startDate":"2025-10","conditions":"Calcium Pyrophosphate Deposition Disease, Rheumatic Diseases","enrollment":137},{"nctId":"NCT05359835","phase":"EARLY_PHASE1","title":"DTPA (Diethylenetriaminepenta-acetate) Chelation for Symptoms After Gadolinium-assisted MRI Exposure","status":"WITHDRAWN","sponsor":"Stanford University","startDate":"2023-04-11","conditions":"Gadolinium Deposition Disease","enrollment":""},{"nctId":"NCT04626609","phase":"","title":"Prostaglandin and Cannabinoid Receptors in EoE","status":"COMPLETED","sponsor":"Medical University of Graz","startDate":"2021-07-01","conditions":"Eosinophilic Esophagitis (EoE)","enrollment":45},{"nctId":"NCT06067503","phase":"PHASE2","title":"Biomarkers to Detect Endocrine Therapy Resistance","status":"RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2024-04-30","conditions":"Metastatic Cancer, Breast Cancer, Lobular Breast Carcinoma","enrollment":8},{"nctId":"NCT02733185","phase":"PHASE3","title":"Trial to Assess Chelation Therapy 2","status":"COMPLETED","sponsor":"Mt. Sinai Medical Center, Miami","startDate":"2016-10-01","conditions":"Diabetes, Myocardial Infarction","enrollment":1000},{"nctId":"NCT04520672","phase":"","title":"Circulating Tumor Cells (CTC) in Cancer","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2020-10-01","conditions":"Cancer","enrollment":3000},{"nctId":"NCT03157167","phase":"PHASE1","title":"An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS)","status":"COMPLETED","sponsor":"Navidea Biopharmaceuticals","startDate":"2017-12-01","conditions":"Kaposi Sarcoma, HIV Infections","enrollment":15},{"nctId":"NCT06368479","phase":"NA","title":"Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Site Settings","status":"COMPLETED","sponsor":"bioLytical Laboratories","startDate":"2024-03-19","conditions":"Hepatitis B, Hepatitis B Infection","enrollment":1400},{"nctId":"NCT05057897","phase":"PHASE4","title":"A Study of AZD1222, a Vaccine for the Prevention of COVID-19 in Immunocompromised Adults","status":"TERMINATED","sponsor":"AstraZeneca","startDate":"2022-01-31","conditions":"COVID-19, SARS-CoV-2","enrollment":34},{"nctId":"NCT05246280","phase":"PHASE3","title":"Tc 99m Tilmanocept Imaging for Early Prediction of Anti-TNFα Therapy Response in Moderate to Severe Active RA","status":"TERMINATED","sponsor":"Navidea Biopharmaceuticals","startDate":"2022-03-02","conditions":"Rheumatoid Arthritis","enrollment":169},{"nctId":"NCT04947137","phase":"PHASE2","title":"Development of a Normative Database for Rheumatoid Arthritis (RA) Imaging With Tc99m Tilmanocept","status":"COMPLETED","sponsor":"Navidea Biopharmaceuticals","startDate":"2021-05-27","conditions":"Rheumatoid Arthritis","enrollment":134},{"nctId":"NCT04078191","phase":"PHASE2","title":"Comparison of Tc 99m Tilmanocept Imaging With IHC Analysis of CD206 Expression in Synovial Tissue of Subjects With RA","status":"TERMINATED","sponsor":"Navidea Biopharmaceuticals","startDate":"2021-09-14","conditions":"Rheumatoid Arthritis","enrollment":20},{"nctId":"NCT03332940","phase":"PHASE1","title":"Safety Evaluation of IV Tc 99m Tilmanocept and Comparison of Imaging With Sulfur Colloid in Subjects With and Without NASH","status":"TERMINATED","sponsor":"Navidea Biopharmaceuticals","startDate":"2017-12-06","conditions":"Nonalcoholic Steatohepatitis, NASH - Nonalcoholic Steatohepatitis","enrollment":6},{"nctId":"NCT03946358","phase":"PHASE2","title":"Combination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers (VolATIL)","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Besancon","startDate":"2020-02-18","conditions":"Squamous Cell Carcinoma of the Head and Neck, Anal Canal Cancer, Cervical Cancer","enrollment":47},{"nctId":"NCT04719988","phase":"PHASE2","title":"Anti-PD-1 and mDCF Followed by Chemoradiotherapy in Patients With Stage III Squamous Cell Anal Carcinoma.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Hospitalier Universitaire de Besancon","startDate":"2022-01-04","conditions":"Squamous Cell Carcinoma of the Anus Stage III","enrollment":55},{"nctId":"NCT06293924","phase":"","title":"Pericardial Fluid Analysis in Recurrent Pericarditis","status":"ENROLLING_BY_INVITATION","sponsor":"ASST Fatebenefratelli Sacco","startDate":"2024-08-18","conditions":"Acute Pericarditis, Pericardial Effusion, Pericardial Disease","enrollment":432},{"nctId":"NCT06647186","phase":"NA","title":"Evaluation of Non-Incised Papillae Surgical Approach (NIPSA) Versus Conventional Flap in Periodontal Reconstructive Surgery of Intrabony Defects (Clinical and Radiographic Study)","status":"COMPLETED","sponsor":"Bassant Hamdy Mowafey","startDate":"2023-06-12","conditions":"Periodontal Bone Loss","enrollment":20},{"nctId":"NCT04829344","phase":"PHASE3","title":"A Study of the Safety and Anesthetic Effect of AG-920 Topical Ophthalmic Solution","status":"COMPLETED","sponsor":"American Genomics, LLC","startDate":"2021-03-30","conditions":"Anesthesia, Local","enrollment":120},{"nctId":"NCT05846568","phase":"PHASE3","title":"Study to Evaluate GR1801's Efficacy and Safety","status":"COMPLETED","sponsor":"Genrix (Shanghai) Biopharmaceutical Co., Ltd.","startDate":"2022-10-21","conditions":"Rabies Post-exposure Prophylaxis","enrollment":1200},{"nctId":"NCT02617407","phase":"PHASE1","title":"Livionex Oral Microbiome and Dental Plaque Control in HSCT Recipients","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2016-07-28","conditions":"Dental Plaque","enrollment":44},{"nctId":"NCT04973449","phase":"PHASE2, PHASE3","title":"Phase II/III Study of AZD2816, for the Prevention of COVID-19 in Adults","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2021-06-27","conditions":"COVID-19, SARS-CoV-2","enrollment":2843},{"nctId":"NCT03982693","phase":"PHASE3","title":"Trial to Assess Chelation Therapy in Critical Limb Ischemia","status":"RECRUITING","sponsor":"Mt. Sinai Medical Center, Miami","startDate":"2019-03-19","conditions":"Critical Limb Ischemia, Diabetes","enrollment":50},{"nctId":"NCT06467643","phase":"NA","title":"Minimally Invasive Root Canal Treatment With Active Disinfection on Single Rooted Teeth With Periapical Lesions","status":"COMPLETED","sponsor":"Saint-Joseph University","startDate":"2023-07-07","conditions":"Radiographic Healing of Periapical Lesions Following Ultrasonic Activation of Heated Sodium Hypochlorite Without Instrumentation of Root Canals","enrollment":19},{"nctId":"NCT03578419","phase":"NA","title":"Small-Volume Tubes to Reduce Anemia and Transfusion","status":"COMPLETED","sponsor":"Population Health Research Institute","startDate":"2019-01-01","conditions":"Blood Loss Anemia","enrollment":27411},{"nctId":"NCT02509598","phase":"PHASE2","title":"A Study of Lymphoseek® as a Lymphoid Tissue Targeting Agent in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node Mapping","status":"COMPLETED","sponsor":"Cardinal Health 414, LLC","startDate":"2015-08","conditions":"Rhabdomyosarcoma, Melanoma","enrollment":24},{"nctId":"NCT05166980","phase":"NA","title":"Study of Multiply-fortified Salt Among Women of Reproductive Age and Preschool Children in India","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2022-10-17","conditions":"Nutrient Deficiency","enrollment":1389},{"nctId":"NCT06178367","phase":"PHASE3","title":"Effectiveness and Safety of Topical Hyaluronic Acid of Different Molecular Weights in Xerotic Skin Treatment","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2023-08-26","conditions":"Xerosis Cutis","enrollment":36},{"nctId":"NCT06386991","phase":"PHASE4","title":"Effect of Different Irrigation Solutions on Postoperative Pain and Lesion Healing","status":"RECRUITING","sponsor":"TC Erciyes University","startDate":"2024-01-01","conditions":"Endodontic Disease","enrollment":39},{"nctId":"NCT06370260","phase":"NA","title":"Assessing the Efficacy of a Hydrogen Peroxide Gel for Oral Wound Healing and Oral Hygiene","status":"COMPLETED","sponsor":"National and Kapodistrian University of Athens","startDate":"2023-05-02","conditions":"Wound Heal, Postoperative Pain, Biopsy Wound","enrollment":54},{"nctId":"NCT06365762","phase":"PHASE1, PHASE2","title":"The Safety and Efficacy Study of Ethylenediaminetetraacetic Acid (EDTA) Ophthalmic Solution in Patients With Loss of Contrast Sensitivity Due to Age-Related, Low-Grade Nuclear Cataract","status":"COMPLETED","sponsor":"Livionex Inc.","startDate":"2006-01-01","conditions":"Age Related Cataracts","enrollment":111},{"nctId":"NCT04980066","phase":"NA","title":"Evaluation of Sticky Bone With or Without EDTA for Treatment of Gingival Recession","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2021-08-03","conditions":"Gingival Recession","enrollment":20},{"nctId":"NCT05786105","phase":"","title":"Optical Genome Mapping in Characterization of Multiple Myeloma","status":"COMPLETED","sponsor":"Institut de cancérologie Strasbourg Europe","startDate":"2023-04-21","conditions":"Multiple Myeloma","enrollment":8},{"nctId":"NCT03554317","phase":"PHASE2","title":"COMbination of Bipolar Androgen Therapy and Nivolumab","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2018-09-05","conditions":"Castration-resistant Prostate Cancer, Metastatic Prostate Cancer, Prostate Cancer","enrollment":45},{"nctId":"NCT02869243","phase":"PHASE1","title":"A Dose Escalation Phase I Study Of Human- Recombinant Bone Morphogenetic Protein 4 Administrated Via CED In GBM Patients","status":"COMPLETED","sponsor":"Stemgen","startDate":"2017-07-18","conditions":"Glioblastoma","enrollment":15},{"nctId":"NCT05236387","phase":"","title":"Evaluating the Ability of 99mTc-Tilmanocept to Identify Clipped Nodes in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy and Sentinel Lymph Node Dissection","status":"TERMINATED","sponsor":"Johns Hopkins University","startDate":"2022-03-01","conditions":"Breast Cancer","enrollment":14},{"nctId":"NCT06244069","phase":"","title":"Clonal Hematopoiesis in Giant Cell Arteritis","status":"NOT_YET_RECRUITING","sponsor":"ASST Fatebenefratelli Sacco","startDate":"2024-03","conditions":"Giant Cell Arteritis, Temporal Arteritis, Clonal Hematopoiesis of Indeterminate Potential","enrollment":326},{"nctId":"NCT02841371","phase":"","title":"Early Screening and Diagnosis of CKD","status":"UNKNOWN","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2009-08-01","conditions":"Kidney; Disease (Functional), Chronic Kidney Disease","enrollment":1000},{"nctId":"NCT06222021","phase":"NA","title":"Hyperlactacidemia in Major Abdominal Surgery and Monocarboxylate Receptors","status":"UNKNOWN","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2024-02","conditions":"Surgical Procedure, Unspecified, Postoperative Complications, Hyperlactatemia","enrollment":109},{"nctId":"NCT06175923","phase":"","title":"Role of BMP Pathway in MDS Progression","status":"NOT_YET_RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2024-01-27","conditions":"Myelodysplastic Syndromes, Acute Myelogenous Leukemia","enrollment":60},{"nctId":"NCT05581706","phase":"NA","title":"Regenerative Endodontics Using Different Intracanal Medicaments on Radiographic Outcomes and Periapical MMP-8 Levels","status":"COMPLETED","sponsor":"Ege University","startDate":"2017-09-01","conditions":"Regenerative Endodontics","enrollment":23},{"nctId":"NCT04096716","phase":"PHASE1","title":"Mapping Draining Lymph Nodes in CNS Malignancies","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2019-12-03","conditions":"Central Nervous System Neoplasms, Central Nervous System Tumor","enrollment":14},{"nctId":"NCT05456555","phase":"NA","title":"The Flapless Approach in Periodontal Regeneration","status":"COMPLETED","sponsor":"University of Turin, Italy","startDate":"2022-09-01","conditions":"Periodontitis, Adult, Intrabony Periodontal Defect","enrollment":46},{"nctId":"NCT04663126","phase":"EARLY_PHASE1","title":"Feasibility of IV Tc-99m-tilmanocept for Imaging of M2-like TAMs in Metastatic Melanoma","status":"TERMINATED","sponsor":"John O. Prior","startDate":"2021-02-01","conditions":"Melanoma","enrollment":5},{"nctId":"NCT00375830","phase":"PHASE2","title":"Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases","status":"COMPLETED","sponsor":"Stanford University","startDate":"2006-01","conditions":"Cancer","enrollment":114},{"nctId":"NCT05878249","phase":"NA","title":"Role Of Wound Lavage in Direct Pulp Capping Of Permanent Teeth With Carious Exposure","status":"UNKNOWN","sponsor":"Postgraduate Institute of Dental Sciences Rohtak","startDate":"2022-11-01","conditions":"Reversible Pulpitis","enrollment":140},{"nctId":"NCT05446324","phase":"PHASE3","title":"Feasibility of Gallium-68-tilmanocept PET/CT for Sentinel Lymph Node Detection in Endometrial Cancer","status":"UNKNOWN","sponsor":"UMC Utrecht","startDate":"2023-02-15","conditions":"Endometrial Cancer","enrollment":10},{"nctId":"NCT05778227","phase":"NA","title":"Comparing Different Single and Combination Chelating Agents on Sealer Penetration and Dentin Erosion.","status":"COMPLETED","sponsor":"Dow University of Health Sciences","startDate":"2021-11-16","conditions":"Root Canal Infection, Periapical Abscess, Irreversible Pulpitis","enrollment":100},{"nctId":"NCT04511026","phase":"PHASE2","title":"Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial Cancer","status":"TERMINATED","sponsor":"Stanford University","startDate":"2021-01-20","conditions":"Endometrial Cancer","enrollment":6},{"nctId":"NCT03938636","phase":"PHASE2","title":"Evaluation of the Precision and Sensitivity of Tilmanocept Uptake Value (TUV) on Tc 99m Tilmanocept Planar Imaging","status":"COMPLETED","sponsor":"Navidea Biopharmaceuticals","startDate":"2019-04-08","conditions":"Rheumatoid Arthritis","enrollment":116},{"nctId":"NCT05124574","phase":"","title":"Transplacental Transmission of COVID-19","status":"TERMINATED","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2021-12-01","conditions":"SARS-COV-2 Infection","enrollment":10},{"nctId":"NCT02798523","phase":"PHASE1","title":"Genomic Responses of Human Immune and Non-Immune Cells to Glucocorticoids","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2017-01-24","conditions":"Normal Physiology","enrollment":33},{"nctId":"NCT04290039","phase":"PHASE1","title":"Sublingual vs IV Atropine Bioavailability Study","status":"COMPLETED","sponsor":"Biomedical Advanced Research and Development Authority","startDate":"2020-01-04","conditions":"Toxic Effect of Organophosphate and Carbamate Insecticides","enrollment":15}],"_emaApprovals":[],"_faersSignals":[{"count":30,"reaction":"AIRWAY REMODELLING"},{"count":30,"reaction":"ASTHMA"},{"count":30,"reaction":"ATOPY"},{"count":30,"reaction":"BLOOD IMMUNOGLOBULIN E INCREASED"},{"count":30,"reaction":"CENTRAL NERVOUS SYSTEM MASS"},{"count":30,"reaction":"CHRONIC SINUSITIS"},{"count":30,"reaction":"CONFUSIONAL STATE"},{"count":30,"reaction":"EOSINOPHIL COUNT DECREASED"},{"count":30,"reaction":"EOSINOPHIL COUNT INCREASED"},{"count":30,"reaction":"EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS"}],"_approvalHistory":[],"publicationCount":26,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Calcium Disodium Versenate","Calcium EDTA","C10H12CaN2Na2O8","Calcium disodium edetate","Calcium Disodium Ethylenediaminetetraacetate"],"phase":"marketed","status":"active","brandName":"Edetate Calcium Disodium","genericName":"Edetate Calcium Disodium","companyName":"M.D. Anderson Cancer Center","companyId":"m-d-anderson-cancer-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Edetate calcium disodium is a chelating agent that binds and removes heavy metals (particularly lead) from the body by forming stable complexes that are excreted in urine. Used for Lead poisoning (acute and chronic lead toxicity), Heavy metal poisoning.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2023-05-03T00:00:00.000Z","mah":"CASPER PHARMA LLC","brand_name_local":"EDETATE CALCIUM DISODIUM","application_number":"ANDA216435"}],"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}